404
Views
7
CrossRef citations to date
0
Altmetric
Commentary

Targeting PECAM-1 for anti-cancer therapy

Pages 121-122 | Published online: 01 Jan 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Horace M. DeLisser. (2011) Modulators of endothelial cell filopodia. Cell Adhesion & Migration 5:1, pages 37-41.
Read now

Articles from other publishers (6)

Yi-Ching Huang, Yi-Shan Tsai, Chung-I Li, Ren-Hao Chan, Yu-Min Yeh, Po-Chuan Chen, Meng-Ru Shen & Peng-Chan Lin. (2022) Adjusted CT Image-Based Radiomic Features Combined with Immune Genomic Expression Achieve Accurate Prognostic Classification and Identification of Therapeutic Targets in Stage III Colorectal Cancer. Cancers 14:8, pages 1895.
Crossref
Nitish Khurana, Abigail Pulsipher, Hamidreza Ghandehari & Jeremiah A. Alt. (2021) Meta-analysis of global and high throughput public gene array data for robust vascular gene expression discovery in chronic rhinosinusitis: Implications in controlled release. Journal of Controlled Release 330, pages 878-888.
Crossref
Benelita T. Elie, Jacob Fernández-Gallardo, Natalia Curado, Mike A. Cornejo, Joe W. Ramos & María Contel. (2019) Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancer. European Journal of Medicinal Chemistry 161, pages 310-322.
Crossref
JIN-SHENG OUYANG, YU-PING LI, CHENG-SHUI CHEN, JUN-JIE CHEN, TONG-KE CHEN, CHANG CAI & LI YANG. (2014) Inhibition of lung tumor growth in nude mice by siRNACD31 targeting PECAM-1. Oncology Letters 8:1, pages 33-40.
Crossref
Gaoyuan Cao, Melane L. Fehrenbach, James T. Williams, Jeffrey M. Finklestein, Jing-Xu Zhu & Horace M. DeLisser. (2009) Angiogenesis in Platelet Endothelial Cell Adhesion Molecule-1-Null Mice. The American Journal of Pathology 175:2, pages 903-915.
Crossref
Joseph R. Carver, Stephen J. Schuster & John H. Glick. (2008) Doxorubicin Cardiotoxicity in the Elderly: Old Drugs and New Opportunities. Journal of Clinical Oncology 26:19, pages 3122-3124.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.